We found that gene signatures that are increased in alternatively activated human MØs and MØs treated with free fatty acids are enriched in early SSc-PF patients and that there is no evidence for enrichment of a pro-inflammatory, IFN-stimulated MØ signature (Fig. 5) [34]. Here, IFNA1 is linked to systemic sclerosis.